Mr. Chair, the donation aspect is based on the availability of the doses each country puts forward.
Canada mentioned very early that we would be donating 200 million doses to COVAX.
There are other countries that have greater access. For example, the U.S. went out and said they would deliver one billion doses of Pfizer. It is not a comparison among the different countries. It is the availability of the doses that are surplus and that we can donate.
We also made efforts in the very beginning to donate those vaccines very early that we deemed we would not be using at all. Those did go to COVAX. We also made bilateral arrangements on that.